A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary CaVβ subunits
Travis J Morgenstern1, Jinseo Park1, Qing R Fan1
1Department of Pharmacology, Columbia University, Vagelos College of Physicians and Surgeons, New York, United States.
Insights
Researchers developed a novel genetically-encoded inhibitor, CaV-aβlator, targeting high-voltage-activated calcium channels (HVACCs). This innovative tool offers precise, versatile inhibition for cardiovascular and neurological disease therapies.
Area of Science:
- Molecular Biology
- Neuroscience
- Cardiology
Background:
- High-voltage-activated calcium channels (HVACCs) are crucial drug targets for cardiovascular and neurological conditions.
- Existing small-molecule inhibitors lack tissue-specificity and versatility.
- Genetically-encoded inhibitors offer potential for enhanced precision and application range.
Purpose of the Study:
- To engineer a novel, genetically-encoded inhibitor for high-voltage-activated calcium channels (HVACCs).
- To assess the efficacy and mechanism of the engineered inhibitor in various cell types and tissues.
- To establish a generalizable platform for developing genetically-encoded modulators of membrane protein complexes.
Main Methods:
- Isolation of a llama nanobody (nb.F3) targeting HVACC CaVβ subunits.
- Fusion of nb.F3 with the Nedd4L E3 ubiquitin ligase HECT domain to create CaV-aβlator.
- Expression and functional assessment of CaV-aβlator in HEK293 cells, cardiomyocytes, neurons, and pancreatic β cells.
- Analysis of CaV1.2 channel trafficking in cardiomyocytes using immunofluorescence microscopy.
Main Results:
- The engineered CaV-aβlator effectively inhibited currents from diverse HVACCs in reconstituted systems and endogenous channels in native cells.
- CaV-aβlator demonstrated efficacy in cardiomyocytes, neurons, and pancreatic β cells.
- In cardiomyocytes, CaV-aβlator induced the redistribution of CaV1.2 channels from dyads to late endosomes.
Conclusions:
- CaV-aβlator represents a potent, genetically-encoded inhibitor of HVACCs.
- This study presents a versatile platform for engineering genetically-encoded modulators of macro-molecular membrane protein complexes.
- The findings open new avenues for targeted therapies in cardiovascular and neurological diseases.
Abstract:
Inhibiting high-voltage-activated calcium channels (HVACCs; CaV1/CaV2) is therapeutic for myriad cardiovascular and neurological diseases. For particular applications, genetically-encoded HVACC blockers may enable channel inhibition with greater tissue-specificity and versatility than is achievable with small molecules. Here, we engineered a genetically-encoded HVACC inhibitor by first isolating an immunized llama nanobody (nb.F3) that binds auxiliary HVACC CaVβ subunits. Nb.F3 by itself is functionally inert, providing a convenient vehicle to target active moieties to CaVβ-associated channels. Nb.F3 fused to the catalytic HECT domain of Nedd4L (CaV-aβlator), an E3 ubiquitin ligase, ablated currents from diverse HVACCs reconstituted in HEK293 cells, and from endogenous CaV1/CaV2 channels in mammalian cardiomyocytes, dorsal root ganglion neurons, and pancreatic β cells. In cardiomyocytes, CaV-aβlator redistributed CaV1.2 channels from dyads to Rab-7-positive late endosomes. This work introduces CaV-aβlator as a potent genetically-encoded HVACC inhibitor, and describes a general approach that can be broadly adapted to generate versatile modulators for macro-molecular membrane protein complexes.
More Related Videos
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Mechanically-gated Ion Channels
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-Protein Gated Ion Channels
Sensory...


